NSC |
Compound |
Enrichment |
Correlation |
NSC 683247 |
Acridine-4-carboxamide, 9-amino-5-methyl- N-[2-(dimethylamino)ethyl]-, dihydrochloride |
0.00192786276806279 |
0.35677983 |
NSC 723906 |
1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline |
0.00192786276806279 |
0.23222589 |
NSC 19441 |
FDA 0283 |
0.00243861794188205 |
0.3922339 |
NSC 526333 |
2,5-Cyclohexadiene-.delta.(1,.alpha.)-acetonitrile, 4-oxo-.alpha.-phenyl-, O-acetyloxime |
0.00243861794188205 |
0.35836786 |
NSC 702106 |
Null |
0.00243861794188209 |
-0.17566307 |
NSC 741212 |
3,3?-(1H-pyrrole-2,5-diyl)bis(5-chloro-1-methyl-1H-indole) |
0.00243861794188209 |
-0.0019633875 |
NSC 92585 |
Benzoic acid, p-[(purin-6-ylthio)mercuri]- |
0.00243861794188209 |
0.066481881 |
NSC 697194 |
Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dimethoxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- |
0.00265989583551648 |
0.27417605 |
NSC 728128 |
1-[3-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2,3-dichlorobenzene |
0.00265989583551648 |
0.26740737 |
NSC 736201 |
Indenoisoquinoline derivative |
0.00265989583551648 |
0.310489 |